We report the case of a 12-year-old girl with severe clinically releva
nt hyponatremia (118 mmol/l) and hypochloremia (81 mmol/l) during trea
tment with oxcarbazepine (OCBZ). The adverse effects were rapidly reve
rsible after discontinuation of OCBZ and did not occur when exposed to
carbamazepine. We reviewed the charts of 48 patients who received OCB
Z as in-patients in our epilepsy centre and found hyponatremia in nine
and hypochloremia in four. The mean sodium level of all patients was
139 mmol/l (range 118-150 mmol/l). We did not see any correlation betw
een sodium or chloride levels and dose of OCBZ or blood serum level of
the active metabolite 10-OH-carbazepine. We emphasize that children a
re at risk of developing electrolyte disturbances during treatment wit
h OCBZ and thus the level of at least sodium should be monitored in th
ose patients. (C) 1998 Elsevier Science B.V. All rights reserved.